<?xml version="1.0" encoding="UTF-8"?>
<p>This high mortality rate is typical among filoviruses, a family of viruses to which the Ebola virus belongs. A related group of African filoviruses, the Marburg and Ravn viruses, also exhibit high mortality rates, and especially among pregnant women and their infants [
 <xref rid="B8-vaccines-08-00038" ref-type="bibr">8</xref>]. Until recently, there were no specific forms of treatment or prevention of Ebola virus infectionâ€”patients were treated symptomatically. However, this situation changed with the advent of the West Africa Ebola epidemic, which was to become the largest in history. By this time, there were not only several medications that had become available for testing, but a recombinant vaccine, the rVSV-ZEBOV (also termed V920) vaccine, produced by Merck that underwent its first human clinical trial during the epidemic.
</p>
